These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17101958)

  • 1. Clopidogrel in patients with acute coronary syndromes: learning from clinical practice.
    Ziegelstein RC
    Arch Intern Med; 2006 Nov; 166(20):2292-3; author reply 2293. PubMed ID: 17101958
    [No Abstract]   [Full Text] [Related]  

  • 2. [Indications of treatment with clopidogrel in the guidelines of the Spanish Society of Cardiology for unstable angina/non-ST-segment elevation acute myocardial infarction].
    Valentín Segura V
    Rev Esp Cardiol; 2002 Nov; 55(11):1217-8; author reply 1218. PubMed ID: 12423582
    [No Abstract]   [Full Text] [Related]  

  • 3. [Guidelines: acute coronary syndrome (ACS)].
    Schwaab B
    Z Kardiol; 2004 Aug; 93(8):634-5; author reply 635-6. PubMed ID: 15338151
    [No Abstract]   [Full Text] [Related]  

  • 4. Building evidence for early initiation of clopidogrel loading in non-ST-segment elevation acute coronary syndromes: going past the American College of Cardiology/American Heart Association guidelines.
    Aghababian RV
    Ann Emerg Med; 2004 May; 43(5):666-8; author reply 668-9. PubMed ID: 15259150
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combination is standard. Dual thrombocyte function inhibition in acute coronary syndrome].
    MMW Fortschr Med; 2004; 146 Suppl 1():8-9. PubMed ID: 15493411
    [No Abstract]   [Full Text] [Related]  

  • 6. Clopidogrel in acute coronary syndromes (unstable angina and non-Q-wave myocardial infarction).
    Heras M; Sionis A
    Drugs Today (Barc); 2003 Apr; 39(4):249-64. PubMed ID: 12743641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of clopidogrel on the rebound hypercoagulable state after heparin discontinuation in patients with acute coronary syndromes.
    Di Nisio M; Bijsterveld NR; Meijers JC; Levi M; Büller HR; Peters RJ
    J Am Coll Cardiol; 2005 Oct; 46(8):1582-3. PubMed ID: 16226189
    [No Abstract]   [Full Text] [Related]  

  • 8. Prasugrel versus clopidogrel for acute coronary syndromes.
    Lynch DR; Dantzler DM; Zhao D
    N Engl J Med; 2013 Jan; 368(2):188. PubMed ID: 23301742
    [No Abstract]   [Full Text] [Related]  

  • 9. Prasugrel versus clopidogrel for acute coronary syndromes.
    Roe MT; Ohman EM;
    N Engl J Med; 2013 Jan; 368(2):188-9. PubMed ID: 23301741
    [No Abstract]   [Full Text] [Related]  

  • 10. We need to do better for patients with non-ST-segment elevation acute coronary syndrome who are managed without revascularization.
    Ohman EM; Harskamp RE
    J Am Coll Cardiol; 2014 Jun; 63(21):2258-60. PubMed ID: 24703912
    [No Abstract]   [Full Text] [Related]  

  • 11. Guideline-based discharge therapy for unstable angina pectoris/non-ST elevation myocardial infarction.
    Richard Conti C
    Clin Cardiol; 2007 Oct; 30(10):489-90. PubMed ID: 17929281
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cost effectiveness of clopidogrel in acute coronary syndromes without ST-elevation (unstable angina, non-Q AMI)].
    Hagymási K
    Orv Hetil; 2004 Jun; 145(23):1251-2. PubMed ID: 15323070
    [No Abstract]   [Full Text] [Related]  

  • 13. New treatment guidelines for unstable angina/non-ST-segment elevation myocardial infartion.
    Howard PA
    Ann Pharmacother; 2002 Nov; 36(11):1800-4. PubMed ID: 12432893
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute coronary syndromes and coronary intervention.
    Lüscher TF
    Eur Heart J; 2015 Feb; 36(6):323-4. PubMed ID: 25660518
    [No Abstract]   [Full Text] [Related]  

  • 15. [Interview with Prof. Dr. H. J. Rupprecht about secondary prevention: what is the optimal thrombocyte function inhibition?].
    Rupprecht HJ
    MMW Fortschr Med; 2004; 146 Suppl 1():9-10. PubMed ID: 15493412
    [No Abstract]   [Full Text] [Related]  

  • 16. [New guidelines in acute coronary syndrome. Clopidogrel for nine months is recommended].
    MMW Fortschr Med; 2002 Oct; 144(40):47. PubMed ID: 12440296
    [No Abstract]   [Full Text] [Related]  

  • 17. Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.
    Chin CT; Roe MT; Fox KA; Prabhakaran D; Marshall DA; Petitjean H; Lokhnygina Y; Brown E; Armstrong PW; White HD; Ohman EM;
    Am Heart J; 2010 Jul; 160(1):16-22.e1. PubMed ID: 20598967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge.
    Tricoci P; Roe MT; Mulgund J; Newby LK; Smith SC; Pollack CV; Fintel DJ; Cannon CP; Bhatt DL; Gibler WB; Ohman EM; Peterson ED; Harrington RA
    Arch Intern Med; 2006 Apr; 166(7):806-11. PubMed ID: 16606819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of clopidogrel in medically managed patients with unstable angina and non-ST-segment elevation myocardial infarction.
    Solomon MD; Go AS; Shilane D; Boothroyd DB; Leong TK; Kazi DS; Chang TI; Hlatky MA
    J Am Coll Cardiol; 2014 Jun; 63(21):2249-57. PubMed ID: 24703914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticlopidine could be an alternative therapy in the case of pharmacological resistance to clopidogrel: a report of three cases.
    Aleil B; Rochoux G; Monassier JP; Cazenave JP; Gachet C
    J Thromb Haemost; 2007 Apr; 5(4):879-81. PubMed ID: 17403206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.